NGNM Financial Facts
GROSS PROFIT: 27.35MSales and marketing: 5.96M
See Full Income Statement
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 355.43M
Cash and cash equivalents: 28.94M
See Full Balance Sheet
NeoGenomics, Inc. (NGNM) Earnings
|
Expand Research on NGNM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +37.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/16/12  |
 |
Q411 | $0.00 | $0.00 | $0.00 | $12.9M | $11.34M | = |  | | Details |
| 10/19/11 |
|
Q311 | $0.00 | -$0.01 | +$0.01 | $11.3M | $10.2M | N/A | | | Details |
| 7/20/11 |
|
Q211 | -$0.01 | -$0.02 | +$0.01 | $10.5M | $9.52M | N/A | | | Details |
